"AKT"ing Lessons for Stem Cells: Regulation of Cardiac Myocyte and Progenitor Cell Proliferation

Trends in Cardiovascular Medicine

Volumn 17, Issue 7, 2007, Pages 235-240

  Sussman, Mark ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B;

CARDIOMYOPATHY; CELL POPULATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC ENGINEERING; HEART DEVELOPMENT; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; PHENOTYPE; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION;

CARDIOMYOPATHIES; CELL PROLIFERATION; HEART; HUMANS; MYOCARDIUM; MYOCYTES, CARDIAC; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-AKT; STEM CELLS;

EID: 34948866710     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2007.08.003     Document Type: Review

References (69)

1. Akala O.O., and Clarke M.F. Hematopoietic stem cell self-renewal. Curr Opin Genet Dev 16 (2006) 496-501
2. Androutsellis-Theotokis A., Leker R.R., Soldner F., et al. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442 (2006) 823-826
3. Ang K.L., Shenje L.T., Srinivasan L., and Galinanes M. Repair of the damaged heart by bone marrow cells: from experimental evidence to clinical hope. Ann Thorac Surg 82 (2006) 1549-1558
4. Anversa P., Rota M., Urbanek K., et al. Myocardial aging-a stem cell problem. Basic Res Cardiol 100 (2005) 482-493
5. Bachmann M., and Moroy T. The serine/threonine kinase Pim-1. Int J Biochem Cell Biol 37 (2005) 726-730
6. Balsam L.B., and Robbins R.C. Haematopoietic stem cells and repair of the ischaemic heart. Clin Sci (Lond) 109 (2005) 483-492
7. Brognard J., Sierecki E., Gao T., and Newton A.C. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 25 (2007) 917-931
8. Bruneau B.G., and Black B.L. The heart's Da Vinci code: a renaissance at Keystone. Development 134 (2007) 1631-1633
9. Chao W., Matsui T., Novikov M.S., et al. Strategic advantages of insulin-like growth factor-I expression for cardioprotection. J Gene Med 5 (2003) 277-286
10. Cheng W., Li B., Kajstura J., et al. Stretch-induced programmed myocyte cell death. J Clin Invest 96 (1995) 2247-2259
11. Cho H.J., Lee J., Wecker A., and Yoon Y.S. Bone marrow-derived stem cell therapy in ischemic heart disease. Regen Med 1 (2006) 337-345
12. Christoforou N., and Gearhart J.D. Stem cells and their potential in cell-based cardiac therapies. Prog Cardiovasc Dis 49 (2007) 396-413
13. Condorelli G., Drusco A., Stassi G., et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A 99 (2002) 12333-12338
14. DeBosch B., Treskov I., Lupu T.S., et al. Akt1 is required for physiological cardiac growth. Circulation 113 (2006) 2097-2104
15. Donath M.Y., and Zapf J. Insulin-like growth factor I: an attractive option for chronic heart failure?. Drugs Aging 15 (1999) 251-254
16. Donath M.Y., Sutsch G., Yan X.W., et al. Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure. J Clin Endocrinol Metab 83 (1998) 3177-3183
17. Elmadbouh I., Haider H., Jiang S., et al. Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol 42 (2007) 792-803
18. Evans S.M., Mummery C., and Doevendans P.A. Progenitor cells for cardiac repair. Semin Cell Dev Biol 18 (2007) 153-160
19. Fazio S., Sabatini D., Capaldo B., et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 334 (1996) 809-814
20. Flores I., Benetti R., and Blasco M.A. Telomerase regulation and stem cell behaviour. Curr Opin Cell Biol 18 (2006) 254-260
21. Forte G., Minieri M., Cossa P., et al. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells 24 (2006) 23-33
22. Fujio Y., Nguyen T., Wencker D., et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101 (2000) 660-667
23. Gao T., Furnari F., and Newton A.C. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18 (2005) 13-24
24. Germani A., Di Rocco G., Limana F., et al. Molecular mechanisms of cardiomyocyte regeneration and therapeutic outlook. Trends Mol Med 13 (2007) 125-133
25. Gnecchi M., He H., Liang O.D., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11 (2005) 367-368
26. Gottlieb R.A., Burleson K.O., Kloner R.A., et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94 (1994) 1621-1628
27. Groszer M., Erickson R., Scripture-Adams D.D., et al. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294 (2001) 2186-2189
28. Gude N., Muraski J., Rubio M., et al. Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ Res 99 (2006) 381-388
29. Gupta S., Das B., and Sen S. Cardiac hypertrophy: mechanisms and therapeutic opportunities. Antioxid Redox Signal 9 (2007) 623-652
30. Hammerman P.S., Fox C.J., Birnbaum M.J., and Thompson C.B. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 105 (2005) 4477-4483
31. Hur J., Yoon C.H., Lee C.S., et al. Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle. Stem Cells (2007)
32. Imanishi T., Hano T., and Nishio I. Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. J Hypertens 23 (2005) 1699-1706
33. Kim S.J., Cheon S.H., Yoo S.J., et al. Contribution of the PI3K/Akt/PKB signal pathway to maintenance of self-renewal in human embryonic stem cells. FEBS Lett 579 (2005) 534-540
34. Kocher A.A., Schlechta B., Gasparovicova A., et al. Stem cells and cardiac regeneration. Transpl Int 20 (2007) 731-746
35. Kucia M., Dawn B., Hunt G., et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 95 (2004) 1191-1199
36. Li Q., Li B., Wang X., et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 100 (1997) 1991-1999
37. Liao R., Pfister O., Jain M., and Mouquet F. The bone marrow-cardiac axis of myocardial regeneration. Prog Cardiovasc Dis 50 (2007) 18-30
38. Lyon A., and Harding S. The potential of cardiac stem cell therapy for heart failure. Curr Opin Pharmacol 7 (2007) 164-170
39. Mathur A., and Martin J.F. Stem cells and repair of the heart. Lancet 364 (2004) 183-192
40. Matsui T., Li L., Wu J.C., et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277 (2002) 22896-22901
41. Matsui T., Nagoshi T., Hong E.G., et al. Effects of chronic Akt activation on glucose uptake in the heart. Am J Physiol Endocrinol Metab 290 (2006) E789-E797
42. McDevitt T.C., Laflamme M.A., and Murry C.E. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J Mol Cell Cardiol 39 (2005) 865-873
43. Mirotsou M., Zhang Z., Deb A., et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A 104 (2007) 1643-1648
44. Mummery C. Cardiomyocytes from human embryonic stem cells: more than heart repair alone. Bioessays 29 (2007) 572-579
45. Nagoshi T., Matsui T., Aoyama T., et al. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 115 (2005) 2128-2138
46. Okano J., Shiota G., Matsumoto K., et al. Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway. Biochem Biophys Res Commun 309 (2003) 298-304
47. Otaegi G., Yusta-Boyo M.J., Vergano-Vera E., et al. Modulation of the PI 3-kinase-Akt signalling pathway by IGF-I and PTEN regulates the differentiation of neural stem/precursor cells. J Cell Sci 119 (2006) 2739-2748
48. Pallante B.A., and Edelberg J.M. Realizing the cardiac stem cell promise: a case for trophism. Regen Med 1 (2006) 217-221
49. Reiss K., Cheng W., Ferber A., et al. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci U S A 93 (1996) 8630-8635
50. Roggia C., Ukena C., Bohm M., and Kilter H. Hepatocyte growth factor (HGF) enhances cardiac commitment of differentiating embryonic stem cells by activating PI3 kinase. Exp Cell Res 313 (2007) 921-930
51. Schuleri K.H., Boyle A.J., and Hare J.M. Mesenchymal stem cells for cardiac regenerative therapy. Handb Exp (2007) 195-218
52. Shiojima I., Sato K., Izumiya Y., et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115 (2005) 2108-2118
53. Shiraishi I., Melendez J., Ahn Y., et al. Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res 94 (2004) 884-891
54. Sohn R.L., Jain M., and Liao R. Adult stem cells and heart regeneration. Expert Rev Cardiovasc Ther 5 (2007) 507-517
55. Su E.J., Cioffi C.L., Stefansson S., et al. Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularization. Am J Physiol Heart Circ Physiol 284 (2003) H1429-H1440
56. Taniyama Y., Ito M., Sato K., et al. Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy. J Mol Cell Cardiol 38 (2005) 375-385
57. Tateishi K., Ashihara E., Honsho S., et al. Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3beta signaling. Biochem Biophys Res Commun 352 (2007) 635-641
58. Taylor D.A. Cell-based myocardial repair: how should we proceed?. Int J Cardiol 95 Suppl 1 (2004) S8-S12
59. Testa J.R., and Bellacosa A. Membrane translocation and activation of the Akt kinase in growth factor-stimulated hematopoietic cells. Leuk Res 21 (1997) 1027-1031
60. Torella D., Rota M., Nurzynska D., et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 94 (2004) 514-524
61. Tsujita Y., Muraski J., Shiraishi I., et al. Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A 103 (2006) 11946-11951
62. Uemura R., Xu M., Ahmad N., and Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98 (2006) 1414-1421
63. Wang L., Ma W., Markovich R., et al. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ Res 83 (1998) 516-522
64. Wang Z., Bhattacharya N., Weaver M., et al. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J Vet Sci 2 (2001) 167-179
65. Welch S., Plank D., Witt S., et al. Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ Res 90 (2002) 641-648
66. Ye P., and D'Ercole A.J. Insulin-like growth factor actions during development of neural stem cells and progenitors in the central nervous system. J Neurosci Res 83 (2006) 1-6
67. Yilmaz O.H., Valdez R., Theisen B.K., et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441 (2006) 475-482
68. Zhang X., and Vik T.A. Growth factor stimulation of hematopoietic cells leads to membrane translocation of AKT1 protein kinase. Leuk Res 21 (1997) 849-856
69. Zhang J., Grindley J.C., Yin T., et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441 (2006) 518-522